Table 1.
This table shows statistical descriptive parameters in the study
| Descriptive Values | Mean ± SD | Range |
|---|---|---|
| Age (Years) | 69.48 ± 8.26 | 43–86 |
| Gender (Female/Male) | 28/22 | |
| Visual Loss Time (Months) | 10.95 ± 6.54 | 1–26 |
| Base Daimeter (Μm) | 828.42 ± 329.38 | 350–1900 |
| Height Of Hole (Μm) | 372.64 ± 86.98 | 217–609 |
| Minimum Diameter (Μm) | 434.7 ± 165.19 | 165–800 |
| Hole Stage | 3.06 ± 0.89 | 2–4 |
| MHI | 0.49 ± 0.16 | 0.21–0.99 |
| HFF | 0.67 ± 0.15 | 0.41–1.10 |
| THI | 1.130.23 | 0.71–1.91 |
| Baseline BCVA, Logmar | 1.23 ± 0.24 | 0.70–1.80 |
| 6th Month BCVA, Logmar | 0.45 ± 0.28 | 0.05–1.3 |
| Baseline Average GCL-IPL Thickness (µm) | 57.98 ± 21.43 | 6-103 |
| Baseline Nasal GCL-IPL Thickness (µm) | 56.94 ± 24.18 | 10–110 |
| Baseline Temporal GCL-IPL Thickness (µm) | 90.16 ± 32.033 | 15–133 |
| Baseline Superior GCL-IPL Thickness (µm) | 59.76 ± 27.04 | 5-130 |
| Baseline Superotemporal GCL-IPL Thickness (µm) | 60.02 ± 22.33 | 10–93 |
| Baseline Superonasal GCL-IPL Thickness (µm) | 60.64 ± 23.96 | 16–114 |
| Baseline Inferotemporal GCL-IPL Thickness (µm) | 60.28 ± 21.77 | 10–89 |
| Baseline Inferonasal GCL-IPL Thickness (µm) | 56.64 ± 23.7 | 21–109 |
| Baseline Inferior GCL-IPL Thickness (µm) | 56.28 ± 25.51 | 16–124 |
| 6th Month Average GCL-IPL Thickness (µm) | 68.7 ± 13.62 | 28–87 |
| 6th Month Nasal GCL-IPL Thickness (µm) | 73.1 ± 15.39 | 22–96 |
| 6th Month Temporal GCL-IPL Thickness (µm) | 93.64 ± 23.38 | 25–98 |
| 6th Month Superior GCL-IPL Thickness (µm) | 69.7 ± 15.92 | 22–96 |
| 6th Month Superotemporal GCL-IPL Thickness (µm) | 61.02 ± 16.01 | 21–82 |
| 6th Month Superonasal GCL-IPL Thickness (µm) | 73.16 ± 17.66 | 21–108 |
| 6th Month Inferotemporal GCL-IPL Thickness (µm) | 65.24 ± 15.88 | 18–91 |
| 6th Month Inferonasal GCL-IPL Thickness (µm) | 71.64 ± 17.09 | 19–108 |
| 6th Month Inferior GCL-IPL Thickness (µm) | 72.76 ± 14.15 | 25–98 |